126 related articles for article (PubMed ID: 11807623)
1. The antimetastatic effect of a single low dose of cyclophosphamide involves modulation of galectin-1 and Bcl-2 expression.
Rabinovich GA; Rubinstein N; Matar P; Rozados V; Gervasoni S; Scharovsky GO
Cancer Immunol Immunother; 2002 Jan; 50(11):597-603. PubMed ID: 11807623
[TBL] [Abstract][Full Text] [Related]
2. Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma model.
Zacarías Fluck MF; Rico MJ; Gervasoni SI; Ilarregui JM; Toscano MA; Rabinovich GA; Scharovsky OG
Cancer Immunol Immunother; 2007 Feb; 56(2):237-48. PubMed ID: 16733672
[TBL] [Abstract][Full Text] [Related]
3. Th2/Th1 switch induced by a single low dose of cyclophosphamide in a rat metastatic lymphoma model.
Matar P; Rozados VR; Gervasoni SI; Scharovsky GO
Cancer Immunol Immunother; 2002 Jan; 50(11):588-96. PubMed ID: 11807622
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the antimetastatic effect of a single low dose of cyclophosphamide on rat lymphoma.
Matar P; Rozados VR; Roggero EA; Bonfil RD; Scharovsky OG
Tumour Biol; 1998; 19(2):69-76. PubMed ID: 9486558
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of antimetastatic immunopotentiation by low-dose cyclophosphamide.
Matar P; Rozados VR; González AD; Dlugovitzky DG; Bonfil RD; Scharovsky OG
Eur J Cancer; 2000 May; 36(8):1060-6. PubMed ID: 10885612
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells but not NKT I cells are modulated by a single low-dose cyclophosphamide in a B cell lymphoma tumor-model.
Rico MJ; Rozados VR; Mainetti LE; Zacarias Fluck MF; Matar P; Scharovsky OG
Exp Oncol; 2012; 34(1):38-42. PubMed ID: 22453147
[TBL] [Abstract][Full Text] [Related]
7. The immune response and the therapeutic effect of metronomic chemotherapy with cyclophosphamide.
Rozados VR; Mainetti LE; Rico MJ; Zacarías Fluck MF; Matar P; Scharovsky OG
Oncol Res; 2010; 18(11-12):601-5. PubMed ID: 20939436
[TBL] [Abstract][Full Text] [Related]
8. Determination of the in vivo effects of cladribine alone and its combination with cyclophosphamide or cyclophosphamide and mitoxantrone on Bax and Bcl-2 protein expression in B-CLL cells.
Kobylinska A; Blonski JZ; Hanausek M; Walaszek Z; Robak T; Kilianska ZM
Oncol Rep; 2004 Mar; 11(3):699-705. PubMed ID: 14767525
[TBL] [Abstract][Full Text] [Related]
9. Chemoprotective and adjuvant effects of immunomodulator ginsan in cyclophosphamide-treated normal and tumor bearing mice.
Shim JY; Han Y; Ahn JY; Yun YS; Song JY
Int J Immunopathol Pharmacol; 2007; 20(3):487-97. PubMed ID: 17880762
[TBL] [Abstract][Full Text] [Related]
10. Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation.
Sturm A; Lensch M; André S; Kaltner H; Wiedenmann B; Rosewicz S; Dignass AU; Gabius HJ
J Immunol; 2004 Sep; 173(6):3825-37. PubMed ID: 15356130
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of galectins in the amelioration of nephrotoxic serum nephritis in Wistar Kyoto rats.
Tsuchiyama Y; Wada J; Zhang H; Morita Y; Hiragushi K; Hida K; Shikata K; Yamamura M; Kanwar YS; Makino H
Kidney Int; 2000 Nov; 58(5):1941-52. PubMed ID: 11044214
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms implicated in galectin-1-induced apoptosis: activation of the AP-1 transcription factor and downregulation of Bcl-2.
Rabinovich GA; Alonso CR; Sotomayor CE; Durand S; Bocco JL; Riera CM
Cell Death Differ; 2000 Aug; 7(8):747-53. PubMed ID: 10918449
[TBL] [Abstract][Full Text] [Related]
13. Galectin fingerprinting by immuno- and lectin histochemistry in cutaneous lymphoma.
Wollina U; Graefe T; Feldrappe S; André S; Wasano K; Kaltner H; Zick Y; Gabius HJ
J Cancer Res Clin Oncol; 2002 Feb; 128(2):103-10. PubMed ID: 11862481
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 expression correlates with apoptosis induction but not tumor growth delay in transplantable murine lymphomas treated with different chemotherapy drugs.
Story MD; Mirkovic N; Hunter N; Meyn RE
Cancer Chemother Pharmacol; 1999; 44(5):367-71. PubMed ID: 10501909
[TBL] [Abstract][Full Text] [Related]
15. Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: biochemical and functional characterization.
Rabinovich GA; Iglesias MM; Modesti NM; Castagna LF; Wolfenstein-Todel C; Riera CM; Sotomayor CE
J Immunol; 1998 May; 160(10):4831-40. PubMed ID: 9590230
[TBL] [Abstract][Full Text] [Related]
16. Expression of galectins-1 and -3 correlates with defective mononuclear cell apoptosis in patients with juvenile idiopathic arthritis.
Harjacek M; Diaz-Cano S; De Miguel M; Wolfe H; Maldonado CA; Rabinovich GA
J Rheumatol; 2001 Aug; 28(8):1914-22. PubMed ID: 11508600
[TBL] [Abstract][Full Text] [Related]
17. Down regulation of T-cell-derived IL-10 production by low-dose cyclophosphamide treatment in tumor-bearing rats restores in vitro normal lymphoproliferative response.
Matar P; Rozados VR; Gervasoni SI; Scharovsky OG
Int Immunopharmacol; 2001 Feb; 1(2):307-19. PubMed ID: 11360931
[TBL] [Abstract][Full Text] [Related]
18. Metronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regression, and is devoid of toxicity.
Rozados VR; Sánchez AM; Gervasoni SI; Berra HH; Matar P; Graciela Scharovsky O
Ann Oncol; 2004 Oct; 15(10):1543-50. PubMed ID: 15367416
[TBL] [Abstract][Full Text] [Related]
19. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
[TBL] [Abstract][Full Text] [Related]
20. Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells.
Schwartz PS; Waxman DJ
Mol Pharmacol; 2001 Dec; 60(6):1268-79. PubMed ID: 11723234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
